Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.
Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chung YS, Kim HM, Han MG, Kim SY, Chin BS. Kim JY, et al. Among authors: kim yj, kim jm, kim hm, kim sy, kim y. J Korean Med Sci. 2020 Feb 24;35(7):e86. doi: 10.3346/jkms.2020.35.e86. J Korean Med Sci. 2020. PMID: 32080991 Free PMC article.
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection.
Kim JY, Jang YR, Hong JH, Jung JG, Park JH, Streinu-Cercel A, Streinu-Cercel A, Săndulescu O, Lee SJ, Kim SH, Jung NH, Lee SG, Park JE, Kim MK, Jeon DB, Lee YJ, Kim BS, Lee YM, Kim YS. Kim JY, et al. Among authors: kim bs, kim sh, kim ys, kim mk. Clin Ther. 2021 Oct;43(10):1706-1727. doi: 10.1016/j.clinthera.2021.08.009. Epub 2021 Aug 23. Clin Ther. 2021. PMID: 34551869 Free PMC article. Clinical Trial.
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019.
Streinu-Cercel A, Săndulescu O, Preotescu LL, Kim JY, Kim YS, Cheon S, Jang YR, Lee SJ, Kim SH, Chang I, Suh JH, Lee SG, Kim MR, Chung DR, Kim HN, Streinu-Cercel A, Eom JS. Streinu-Cercel A, et al. Among authors: kim jy, kim sh, kim mr, kim hn, kim ys. Open Forum Infect Dis. 2022 Feb 2;9(4):ofac053. doi: 10.1093/ofid/ofac053. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35295819 Free PMC article.
The First Case of Monkeypox in the Republic of Korea.
Jang YR, Lee M, Shin H, Kim JW, Choi MM, Kim YM, Lee MJ, Kim J, Na HK, Kim JY. Jang YR, et al. Among authors: kim jy, kim ym, kim j, kim jw. J Korean Med Sci. 2022 Jul 11;37(27):e224. doi: 10.3346/jkms.2022.37.e224. J Korean Med Sci. 2022. PMID: 35818706 Free PMC article.
Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.
Kim H, Jang YR, Lee JY, Ko JH, Lee JY, Cho S, Lee YD, Song J, Hyun M, Kim HA, Hwang S, Ryou S, Na YJ, Lee JY, Lee C, Lee NY, Shin S, Kwon KT, Kim JY, Peck KR. Kim H, et al. Among authors: kim jy, kim ha. Front Cell Infect Microbiol. 2023 May 15;13:1192512. doi: 10.3389/fcimb.2023.1192512. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37256107 Free PMC article.
12,184 results
You have reached the last available page of results. Please see the User Guide for more information.